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TO THE EDITOR Null mutations in the epidermal barrier protein filaggrin (FLG) cause ichthyosis vulgaris (IV, Smith et al., 2006) and are a major risk factor for eczema and other atopic diseases (Palmer et al., 2006; Baurecht et al., 2007; Brown et al., 2008a; Henderson et al., 2008) . About 10% of European patients are heterozygous for such null mutations (Sandilands et al., 2006) , but clinical details of their skin phenotype are sparse. A recent study of 811 English children reported that mild ichthyosis, palmar hyperlinearity, and keratosis pilaris were commoner in carriers of null mutations (Brown et al., 2008a) . We report the effect of heterozygosity for FLG null alleles, and age, on the prevalence of simple subjective or objective clinical features of ''dry skin'' in adults and elderly patients not selected for inflammatory skin disease.
Patients referred for diagnosis of a discrete skin lesion to dermatology clinics in Glasgow were recruited in two age cohorts: young adults 18-40 years (192 patients; 82 men, 110 women) , and the elderly 60-75 years (99 patients; 55 men, 44 women). Patients were asked not to apply body moisturizers for 48 hours before their appointment; sunbed users or those who had been on a sunny holiday within 6 weeks were excluded. The protocol was approved by the South Glasgow Research Ethics Committee, conformed to the Declaration of Helsinki Principles, and written informed consent was obtained. The study took place in all months of the year, in a climate without extreme variation in humidity, and all assessments took place before genotyping. A questionnaire asked patients whether they considered they had dry skin (possible responses, coded 0-3, were not at all, a little, moderately, or a lot), sensitive skin (same responses) and how often they used a moisturizer for the body (never, now and again, more than once a week, or daily), and sought a history of childhood eczema or other diseases. Trained observers made objective assessments of visible fine scale and of roughness in each of three body sites (volar forearms, lower legs, and lower back), of keratosis pilaris (upper arms only), and of increased palmar markings and texture. A simple scoring scale for each parameter was used: absent (0), just perceptible (1), obvious (2), and marked (3). The total score of these parameters (maximum 27) was used as a summary measure of ''dry skin''. DNA, extracted from whole blood using standard procedures, was genotyped for four FLG null mutations common in the UK (R501X, 2282del4, R2447X, and S3247X) as described (Palmer et al., 2006; Sandilands et al., 2007) with minor refinements (Table  S1 ). Statistical comparisons were made in 284 patients in whom all four mutations were successfully typed, between those wild-type sequence at all loci (wt) and patients heterozygous for only one of the mutations (null).
Of 284, 252 (89%) patients were wild type for all four mutations; 29 (10.2%) were heterozygous for one null mutation, and 3 (1%) were compound heterozygotes, R501X/R2447X, 2282del4/ S3247X, and R2447X/S3247X. The frequency of these alleles was consistent with the previous UK data (Table S2; Sandilands et al., 2007; Brown et al., 2008b) . Four patients in whom the assessors commented on marked scaling consistent with IV included all three compound heterozygotes; the fourth was heterozygous only for R501X but on biopsy showed a reduced granular layer, consistent with previous immunohistochemical analysis indicative of an undetected second null mutation (Sandilands et al., 2007) ; for financial reasons, this patient was not subjected to full sequencing.
Questionnaire results are shown in Figure 1a and Table S3 . Women were highly significantly more likely than men to consider they had dry skin (39 vs 11%) or use body moisturizers regularly (43 vs 7%). Heterozygous carriers of null mutations were more likely to think they had dry skin Total scores for signs of dry skin are increased in carries of null alleles. Population distribution of individual total scores for features of dry skin in 238 patients with (left) wild-type sequence at all four polymorphisms tested and (right) 27 patients carrying one null mutation in FLG and two compound heterozygotes (the latter shown by *); note the 10-fold difference in scale. 18 patients typed, including two heterozygotes and one compound heterozygote, were excluded from assessment of signs because they had used body moisturizer within 48 hours. The subject who scored 18 was thought clinically to have IV, and granular layer was absent on biopsy. He may be carrying a second mutant allele not identified in this study.
www.jidonline.org 1043 A Sergeant et al.
Filaggrin Null Alleles and Dry Skin ''moderately'' or ''a lot'' (Fisher's exact test; P ¼ 0.024), to due principally men, and not significant in women alone. Use of body moisturizers twice a week or more was commoner among carriers, but again this finding was significant only in men (P ¼ 0.035). Self-perceived sensitive skin (''moderately'' or ''a lot'') was no more common among carriers. Carriers were more likely to give a history of childhood eczema (P ¼ 0.009), but asthma and hay fever were not significantly more common in this study. Trends to fewer cases of acne and psoriasis in carriers were not significant.
In the objective assessments, the prevalence of fine scaling and roughness of the skin, keratosis pilaris, and of palmar hyperlinearity and roughness (a score of 1 or more) were all increased in carriers ( Figure 1b ). For most parameters this was significant by Fisher's exact test (Table S3 ). Distribution of total skin signs in wild-type and carrier populations is shown in Figure 2 ; 94% of young non-carriers had a score of 4 or less and thus a total score 44 was chosen to define clinical ''dry skin''. By this criterion, using binary logistic regression, heterozygous carriers were more likely than non-carriers to have dry skin (odds ratio 7.3, 95% confidence interval 2.9-18.6, P ¼ 0.00002; P ¼ 0.003 in each age cohort). Independently of genotype, the elderly were more likely to have dry skin than younger adults (odds ratio 2.9, 95% confidence interval 1.3-6.3, P ¼ 0.007). Seventy percent of young adult carriers exhibited some features of dry skin (a score of 1 or more in any parameter) but so did 47% of young non-carriers. All the older carriers had some evidence of dry skin, but so did 70% of non-carriers. In identifying young carriers clinically, fine scale on the legs was helpful (53% of carriers vs 22% of non-carriers) but most older patients had scaling on the legs irrespective of genotype. In the latter group, fine scaling on the arms, or palmar hyperlinearity (63 vs 27%, and 50 vs 11%, respectively) provided better opportunities to make a clinical distinction.
In this adult population, ascertained independently of dry or inflamed skin, the prevalence of null mutations was identical to previous UK populations who had not been ascertained. We chose to study patient perception and simple clinically assessed surface changes, to reflect the usage of the term ''dry skin'' by patients and practitioners in everyday life. This is less objective than physiological correlates of altered skin surface such as transepidermal water loss and stratum corneum hydration. Despite this, there was a clear effect of FLG mutation on the clinical measures. The finding that heterozygous carriers have an increased prevalence of dry skin is also consistent with studies with potential recruitment bias (for example, Novak et al., 2008, ascertained for contact eczema; Kezic et al., 2008, recruited by advertisement). We also confirm the recent population survey in English schoolchildren showing increased dry skin, an increased incidence of childhood eczema, and a surprisingly high prevalence of clinical IV (Brown et al., 2008a) .
However, even with the loosest criteria for dry skin, penetrance is at most 70% in young patients and nearly 50% of non-carriers have some positive findings. Signs such as keratosis pilaris and palmar hyperlinearity are suggestive but nonspecific, and though summary skin scores were highly significantly different between groups they have poor predictive values at an individual level. Less than a third gave a history of eczema. Thus, although null mutations in FLG are a major contributing factor to clinical dry skin and eczema in the population, additional factors influence expression of these phenotypes. These may include the number of FLG repeats per allele, which varies from 10 to 12 (Ginger et al., 2005) , or variations in the expression of FLG or other protein or lipid components of the cornified layer. The latter include ceramides, whose decline may be responsible for increasingly dry skin with age (Rogers et al., 1996) . Further study of protein and lipid expression in the skin is required to identify the molecular correlates of clinical dry skin, impaired barrier function, and predisposition to eczema in carriers of FLG null mutations.
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SUPPLEMENTARY MATERIAL

Case 1
A 62-year-old Japanese man presenting with a solitary, asymptomatic, well-circumscribed, round, nonerythematous macule on the plantar arch of the right sole, which had persisted for 2 years (Figure 1a ). The lesion had increased in size gradually, and the diameter was 12 mm. Topical steroids and antibiotics were of no benefit. Bacterial cultures were negative. Dermoscopic views using jelly immersion showed regularly distributed whitish spots with round pigmentation corresponding to the pigmented acrosyringeum (data not shown). Furrows and ridges were obscure but maintained.
Histological examination showed an abrupt and substantial decrease in the thickness of the stratum corneum (Figure 1b) . The corneum in the involved skin showed typical basket-wave orthokeratosis. The lesional epidermis was thinner and its granular layer was reduced when compared to adjacent noninvolved skin. However, lesional sweat glands did not show these characteristic features. The acrosyringeal structures, including thick cornified and granular layers, remained similar in appearance to the surrounding intact skin (Figure 1c ). Multiple slices detected no cornoid lamella. Nuclear size and quality of cytoplasm in keratinocytes from lesional skin was subtly disrupted, but there was no pleomorphism. There was no lymphocyte infiltration or dilated vessels in the papillary dermis. Connective tissue in the dermis looked normal on heamatoxylin and eosin (HE) staining. The density and shape of dermal fibroblasts located beneath the affected epidermis did not differ from those in adjacent normal dermis. Immunohistochemical examination revealed that K9 expression at the lesional epidermis diminished abruptly at the transition from intact sole skin; however, the acrosyringeal keratinocytes scattered in the hypokeratotic macula continued to show strong expression of K9 (Figure  2a and b) . In contrast, lesional keratinocytes showed robust keratin 10 (K10) expression, as compared to the subtle K10 expression in the surrounding sole epidermis (Figure 2c and d) . Expression of K6 and K16 showed no marked difference between normal and lesional skin (data not shown). Involucrin and filaggrin showed slightly decreased expression in the involved epidermis when compared to the adjacent normal skin (data not shown). The expression of Cx26, which is known to be abundant in the palm-plantar keratinocytes, also diminished notably at the hypokeratotic lesional keratinocytes. The acrosyringeal keratinocytes exclusively retained Cx26 expression (Figure 2e and f ) .
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Circumscribed Palmo-Plantar Hypokeratosis
